Style | Citing Format |
---|---|
MLA | A Tahmasebzadeh ATEFEH, et al.. "Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures." Frontiers in Biomedical Technologies, vol. 12, no. 3, 2025, pp. 557-563. |
APA | A Tahmasebzadeh ATEFEH, H Kaeidi HOSEIN, M Kaeedi MARYAM, R Paydar REZA (2025). Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures. Frontiers in Biomedical Technologies, 12(3), 557-563. |
Chicago | A Tahmasebzadeh ATEFEH, H Kaeidi HOSEIN, M Kaeedi MARYAM, R Paydar REZA. "Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures." Frontiers in Biomedical Technologies 12, no. 3 (2025): 557-563. |
Harvard | A Tahmasebzadeh ATEFEH et al. (2025) 'Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures', Frontiers in Biomedical Technologies, 12(3), pp. 557-563. |
Vancouver | A Tahmasebzadeh ATEFEH, H Kaeidi HOSEIN, M Kaeedi MARYAM, R Paydar REZA. Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures. Frontiers in Biomedical Technologies. 2025;12(3):557-563. |
BibTex | @article{ author = {A Tahmasebzadeh ATEFEH and H Kaeidi HOSEIN and M Kaeedi MARYAM and R Paydar REZA}, title = {Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures}, journal = {Frontiers in Biomedical Technologies}, volume = {12}, number = {3}, pages = {557-563}, year = {2025} } |
RIS | TY - JOUR AU - A Tahmasebzadeh ATEFEH AU - H Kaeidi HOSEIN AU - M Kaeedi MARYAM AU - R Paydar REZA TI - Dose Assessment and Evaluation of Cancer Risk Due to Prevalent Ct Scan Procedures JO - Frontiers in Biomedical Technologies VL - 12 IS - 3 SP - 557 EP - 563 PY - 2025 ER - |